Clinical Trial Update: Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate the efficacy and safety of adalimumab in adults with moderate to severe chronic plaque psoriasis. The study is completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Abbott | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2010-11-19